Accelerator Competition: Regenerative Medicine at the Front Line

Funding opportunity:

Accelerator Competition: Regenerative Medicine at the Front Line



Funder & programme:

Defence and Security Accelerator (DASA) – Accelerator Competition


Up to £ 500,000 (Phase 1);

Up to £500,000 (Phase 2)

Phase 1 opens:




This Defence and Security Accelerator (DASA) themed competition seeks to make a real difference in saving lives and reducing disability following serious injury. DASA is looking for proposals that harness developments in regenerative medicine to offer practical approaches suitable for use early after injury.

Recent conflicts in Iraq and Afghanistan saw step changes in trauma care that led to great improvements in survival following blast or ballistic trauma. This has meant, however, that people survive with increasingly life-changing injuries.

DASA’s belief is that the very early use of approaches in regenerative medicine, one of the UK Government’s 8 great technologies, has the potential to further revolutionise front line trauma care to save lives and to improve the quality of life for survivors.

This competition has 2 challenges:

  • bioengineered blood and blood components;
  • the preservation and regeneration of soft tissue using biophysical approaches

The outputs from this work would be developed for use by the UK’s Defence Medical Services and other organisations who deliver trauma care in challenging environments. These approaches should also reduce the burden on later care supplied by both MoD and the NHS.

Up to £500,000 is available for phase 1 of this competition. At least another £500,000 will be made available for phase 2 of the competition. Only those projects funded through phase 1 will qualify for entry into the phase 2 competition.

MSC R&D can help your business develop by supporting you in:
• Identification of appropriate grants and competition calls for proposals
• Partner search for collaborative Research & Innovation
• Bid writing
• Project management
• Audit compliance
• Commercialisation
• Business Planning
• Market Intelligence reports

If you want help with any of these opportunities, please CONTACT us on 0114 230 8401 or email